Dr. Behari is a Professor whose research investigates the role of intracellular signaling pathways in the pathogenesis of liver diseases. He is also interested in nonalcoholic fatty liver disease, alcoholic fatty liver disease and hepatocellular carcinoma.
- MBBS, University of Rajasthan, 1993
- PhD, University of Georgia, 1998
- Internal Medicine Residency, University of Massachusetts, 2002
- Internal Medicine Residency, University of Pittsburgh, 2003
- Fellowship, Gastroenterology/Hepatology, University of Pittsburgh, 2006
- Research Fellowship, Massachusetts General Hospital/ Harvard Medical School, 2000
Education & Training
Cormack JM, Lee HO, Chao YH, Kim K, Behari J. Focused Shear Wave Elastography to Assess Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Gastro Hep Adv. 2025 Dec 1;5(3):100855. PMID: 41586346.
Molinari M, Kaltenmeier C, Samra PB, Liu H, Wessel C, Lou Klem M, Dharmayan S, Emmanuel B, Al Harakeh H, Tohme S, Geller D, Tevar A, Hughes CB, Humar A, Bataller R, Behari J. Hepatic Resection for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of 7226 Patients. Ann Surg Open. 2021 May 3;2(2):e065. PMID: 37636554.
Arnouk J, Rachakonda VP, Jaiyeola D, Behari J. Differential Outcomes and Clinical Challenges of NAFLD With Extreme Obesity. Hepatol Commun. 2020 Jul 21;4(10):1419-1429. PMID: 33024913.
Rachakonda VP, DeLany JP, Kershaw EE, Behari J. Impact of Hepatic Steatosis on Resting Metabolic Rate and Metabolic Adaptation in Response to Intentional Weight Loss. Hepatol Commun. 2019 Aug 21;3(10):1347-1355. PMID: 31592493.
Rachakonda V, Argemi J, Borhani AA, Bataller R, Tevar A, Behari J. Reduced Serum Sphingolipids Constitute a Molecular Signature of Malnutrition in Hospitalized Patients With Decompensated Cirrhosis. Clin Transl Gastroenterol. 2019 Mar;10(3):e00013. PMID: 30908309.
Rachakonda V, Borhani AA, Dunn MA, Andrzejewski M, Martin K, Behari J. Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis. PLoS One. 2016 Sep 1;11(9):e0159142. PMID: 27583675.
Rachakonda V, Gabbert C, Raina A, Li H, Malik S, DeLany JP, Behari J. Stratification of risk of death in severe acute alcoholic hepatitis using a
panel of adipokines and cytokines. Alcohol Clin Exp Res. 2014 Nov;38(11):2712-21. PMID: 25421508.
Rachakonda V, Gabbert C, Raina A, Bell LN, Cooper S, Malik S, Behari J. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways. PLoS One. 2014 Dec 2;9(12):e113860. PMID: 25461442.
Dudekula A, Rachakonda V, Shaik B, Behari J. Weight loss in nonalcoholic Fatty liver disease patients in an ambulatory care setting is largely
unsuccessful but correlates with frequency of clinic visits. PLoS One. 2014 Nov 6;9(11):e111808. PMID: 25375228.
Ganesh S, Rogal SS, Yadav D, Humar A, Behari J. Risk factors for frequent readmissions and barriers to transplantation in patients with cirrhosis. PLoS One. 2013;8(1):e55140. PMID: 23383085.
- Ruth L. Kirschstein National Research Service Award, 2004-2006
- Poster of Distinction, 56th Annual Meeting of AASLD, 2005
- UPMC Award for Commitment and Excellence in Service (ACES), 2024
R01 CA255809, Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes, MPI, 2021-2026.
University of California San Diego 704212, GOLDMINE: Global Longitudinal Assessment of Nonalcoholic Fatty Liver Disease (NAFLD) using Magnetic Resonance Elastography, Site PI, 2022-2027.
Madrigal Pharmaceuticals METEOR NET-SOW1, MASLD Early Detection, Treatment Optimization and Referral Network (METEOR Net), PI, 2025-2027.
